DVAX
Dynavax Technologies Corporation · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website dynavax.com
- Employees(FY) 351
- ISIN US2681582019
Performance
-9.85%
1W
+11.14%
1M
+6.29%
3M
+9.54%
6M
-12.95%
YTD
-11.04%
1Y
Profile
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Technical Analysis of DVAX 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-19 08:50
- 2024-11-12 19:00
DVAX: Raising target price to $11.00(Argus Research)
- 2024-11-11 12:00
- 2024-11-11 09:55
- 2024-11-11 08:43
- 2024-11-11 08:00
- 2024-11-10 19:00
- 2024-11-10 09:01
- 2024-11-09 07:48
- 2024-11-08 12:02
- 2024-11-08 09:07
- 2024-11-08 06:22
- 2024-11-07 23:15
- 2024-11-07 17:25
- 2024-11-07 16:18
Dynavax Technologies: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-11-07 16:02
- 2024-11-07 16:01
- 2024-11-07 03:02
- 2024-11-07 03:01
- 2024-11-05 19:00
DVAX: Raising target price to $10.00(Argus Research)
- 2024-11-05 09:30
- 2024-11-01 18:33
- 2024-10-29 10:12
Dynavax Technologies Adopts Poison Pill(MT Newswires)
- 2024-10-29 08:30
- 2024-10-28 20:30
- 2024-10-24 21:08
- 2024-10-24 16:10
- 2024-10-24 04:10
- 2024-10-22 10:02
- 2024-10-16 13:04
Page 1 of 8
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.